Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Alphageddon it may be Polygon or a.n.other that is will to offer a CFD's...
Either way we know Polygon won't stop now, they could be acting on behalf of some pharma company (buying stock cheaply) but the purchase of CFD's which do have a time period means they are most probably working on a sub 3 month timeframe.
Not much longer now...
alkin - it would be interesting if Polygon have started buying shares again today. Dont forget from the last TR1 on 26th October that it showed they had stopped all share acquisition since at least 21st October - they had switched to paying for CFD's instead to presumably increase the leverage on their capital.
Some of the big trades this morning were Auction bids, suspect these are coming from investment houses like Polygon...
Mike109:
Yes he did! Thank you for the reminder.
RM said he would need government support in ramping up manufacturing and the government have stated
“ The UK government has announced an Antivirals Taskforce with the aim of identifying and deploying Covid-19 treatments as early as autumn.
The taskforce will search for the most promising novel antiviral medicines that can be easily taken at home, and to support their development through clinical trials, the government announced on 20 April. It will also look at opportunities to manufacture antiviral treatments in the UK.”
We also know through HHS that the USA are supporting manufacturing of promising drugs.
*Guilty look*
"At the end of the day, we are all just speculating unless of course you (generic) secretly work for one of the interested parties!" You are right of course Mact4, all speculation. BB's are a great source of information regarding investor sentiment. Many questions have been asked here and opinions sought - about how many shares are owned, stop losses in place, sell out points, deduced risk appetite, favoured scenarios, etc etc. All highly valuable information in certain hands. I'll just park that there for digesting later. GLA.
Silence Therapeutics (SLN) have recently announced they are delisting from AIM and listing on the NASDAQ.
It will be interesting to see how that works out for them...
*Sigh*
The discussion started with "expedite manufacturing of drugs and devices" from an earlier post and the current cash in hand may not be enough to do so.
JV and licensing will likely be the way forward - certainly best for LTH and STH!
At the end of the day, we are all just speculating unless of course you (generic) secretly work for one of the interested parties!
The landscape is fast changing but will carry on trusting RM and the BoD to continue to make the best decisions for the company.
to clarify, I mean "end" 2022.
They don't need to raise funds. Enough cash in the bank until 2022 outside of P3, isn't that what RM said at interims? There's no cap and begging bowl scenario here. Assuming P3 delivers a drug to the current market (in grave need), there absolutely will be more than one interested party. Polygon's sudden lurch forward indicates that may be in play. I'd love to see multiple licence agreements in place with Synairgen getting a fat wadd of $$$ to take other treatments forward in the future. They are not the company they were 5 years ago and the market is chomping at the bit for more drugs to fill hungry pipelines.
T/O will be too soon, and I believe contrary to what RM has indicated previously.
Unless of course, that is what Polygon and Polar dictate with their increasing % of voting rights.
Nasdaq initial listing will spell disaster for LTH's in the short and medium term (we would have to hold a lot longer for any real big gains if that were too happen). Just look at ARB and TILS - Complete sh*T show. It is not always the holy grail everyone alludes to. Defo do not want that it far too much of an uptick in risk.
I appreciate it can go both ways, but not something I think we need to even debate, let alone actually consider doing.
To be fair based on the Polygon interest and the ease at which SNG raised £80m last year, if they have the orders raising capital would be a breeze. That said if the USA was to be SNG's biggest market, it would hurt them being known more over there but I really hope we will have SNG over here, that is ultimately why I have invested in SNG.
Nice though that the profit takers are making it cheap for Polygon and others to buy more shares, if you look at the data its obvious larger positions are being taken
Context.
My speculation of listing on the Nasdaq was because this could be an alternative way of raising a lot of cash, rather than parting with 20-25% with a pharma as speculated by BigJohnnyWin.
All this is just speculation in-between news!
Bruce, a listing on the Nasdaq would raise awareness of Synairgen and they would probably issue more shares.
We know countries like to have a slice of the pie and if this course of action was taken, you would see a big upsurge in the SP on both sides of the pond.
How would listing on NASDAQ raise extra cash? strange ideas swilling around
or again maybe not
There are at least 100,000 patients in hospital with Covid according to
https://ourworldindata.org/covid-hospitalizations
If you add in those covid+ new cases where sng001 may help, then it can be assumed the demand for a drug that may save 70-80% of lives will be in very high demand. Maybe sng will be advised to pass it to a few major pharmaceutical companys to allow them to make it and dispense on a humankind endeavour with sng getting a royalty on each dose.
Perhaps or maybe the US govt might assist with some upfront costs, as they have done with another Covid therapeutic (sorry I am terrible at remembering names). There is also a case for another re-rating of SP - if SNG was listed on theNASDAQ. That could also help raise the necessary cash.
Perhaps the more informed here might tell me if this idea has merit or is dead in the water!
I suspect, but I may be wrong, that synairgen will have a tie-up/jv up their sleeve whereby they will receive say £200m from a partner for about 25-40% of new synairgen shares and the money used to expedite manufacturing of drugs and devices. On top of this advance orders from USA for maybe up to USD500m for an upfront order. I suspect BungleBoris and his bunch of idjiots will be shut out as USA will take anything produced. My friend a Bioscientist reckons that upscaling the manufacturing of interferon would not be too much of a problem if sng have the readies. A deal such as that would in my opinion propel SP to over £6. Just my thoughts
The CFDs basically means Polygon are throwing the kitchen sink at this and the fact they are leveraged tells you how confident they are. Money is in short supply at the moment but I’ve followed their lead today with a modest top up.
alkin - I did a post a few days ago as to why I think Polygon secured the voting rights. The proceeds from the CFDs, once closed out, would be used to acquire the underlying shares from the other parties. They may have done it as it requires less upfront capital which may be in limited supply at the moment. This is what I suspect is happening and would explain why they have the voting rights.
Deal3r, I agree with Matterhorn that there must be an agreement in place (which probably means they paid more for the CFD) to have voting rights.
The question we should be asking is why these rights are important?
It’d be a structured trade Polygon entered into whereby voting rights are transferred via another agreement which is in addition to the CFD which does not transfer voting rights.
From an accounting perspective they’d be the share owners since they control the shares - substance over (legal) form.
Deal3r
My view is that Polygon are holding the shares for A,N Other.